BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2008

View Archived Issues

Clinical data on elotuzumab in multiple myeloma emerging

Read More

Antineoplastons induce responses in anaplastic astrocytoma patients

Read More

Synergy successfully completes phase I trial of SP-304 in healthy subjects

Read More

ITI presents development update of ITI-111 for acute repetitive seizure in epilepsy

Read More

Novel agents for treating HCV infection jointly disclosed by Array and InterMune

Read More

Novavax reports preclinical results from study of RSV vaccine in mice

Read More

Wyeth initiates phase I study of Ablynx Nanobody targeting TNF-alpha

Read More

Cytos initiates phase IIb clinical study of CYT003-QbG10 for allergy and asthma

Read More

Futura reports results from phase I study of PET-500 for premature ejaculation

Read More

Neogenix to initiate clinical trial of monoclonal antibodies for colorectal and pancreatic cancer

Read More

Javelin reports results from phase III efficacy study of Dyloject in postsurgical pain

Read More

Clinical results disclosed for a novel inhibitor of sodium and calcium channels in epilepsy

Read More

Arana commences international phase II trial of ART-621 in rheumatoid arthritis

Read More

Calcineurin inhibition can guide dosing of voclosporin in plaque psoriasis patients

Read More

InterMune to report triple combination ITMN-191 study results in January

Read More

CBP-501 enters phase II trials for malignant pleural mesothelioma

Read More

Halozyme starts dosing in phase I trial of bisphosphonate plus rHuPH20 enzyme

Read More

KAI-1678 enters phase IIa trials for the treatment of pain

Read More

Palatin and AstraZeneca extend research collaboration and license agreement

Read More

Alexza reports positive results from phase III clinical trial of AZ-004 in bipolar disorder

Read More

Almirall reports positive results from phase IIa study of LAS-100977 in asthma

Read More

Novel Pan-PI3 kinase inhibitor identified for leukemia and myeloma

Read More

Recent patents describe new treatment options for endocrine-associated disorders

Read More

Recent patents disclose new treatments for obesity

Read More

FDA approves Lusedra for sedation in diagnostic or therapeutic procedures

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing